Cite
HARVARD Citation
Tosti, P. et al. (n.d.). The anti-leukemic drug nilotinib inhibits metastatic properties of colorectal cancer cells by targeting the receptor tyrosine kinase DDR1. European journal of cancer. pp. S148-S149. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tosti, P. et al. (n.d.). The anti-leukemic drug nilotinib inhibits metastatic properties of colorectal cancer cells by targeting the receptor tyrosine kinase DDR1. European journal of cancer. pp. S148-S149. [Online].